Felix G Fernandez1, Andrzej S Kosinski2, Anthony P Furnary3, Mark Onaitis4, Sunghee Kim2, Robert H Habib5, Betty C Tong6, Patricia Cowper2, Daniel Boffa7, Jeffrey P Jacobs8, Cameron D Wright9, Joe B Putnam10. 1. Department of Surgery, Emory University School of Medicine, Atlanta, Ga. Electronic address: felix.fernandez@emoryhealthcare.org. 2. Department of Biostatistics, Duke University, Durham, NC. 3. Starr-Wood Cardiothoracic Group, Portland, Ore. 4. Department of Surgery, University of California San Diego, San Diego, Calif. 5. Society of Thoracic Surgeons Research Center, Chicago, Ill. 6. Department of Surgery, Duke University, Durham, NC. 7. Department of Surgery, Yale University, New Haven, Conn. 8. Department of Surgery, Johns Hopkins All Children's Hospital and Johns Hopkins University, St Petersburg, Fla. 9. Department of Surgery, Massachusetts General Hospital, Boston, Mass. 10. Baptist MD Anderson Cancer Center, Jacksonville, Fla.
Abstract
OBJECTIVE: Complications adversely affect survival after lung cancer surgery. We tested the hypothesis that effects of complications after lung cancer surgery on survival vary substantially across the spectrum of postoperative complications. METHODS: The Society of Thoracic Surgeons General Thoracic Surgery Database was linked to Medicare data for lung cancer resections from 2002 through 2013. Linkage was achieved for 29,899 patients. A survival model was created that included operative complications as explanatory variables and adjusted for relevant baseline covariates. Because of violation of the proportional hazard assumption, we used time-varying coefficient Cox modeling for the complication variables. RESULTS: Median patient age was 73 years, and 48% were male. Procedures performed were lobectomy in 69%, wedge in 17%, segmentectomy in 7%, bilobectomy in 3%, pneumonectomy in 3%, and sleeve lobectomy in 1%. Most frequent complications were atrial arrhythmia (14%), pneumonia (4.3%), reintubation (3.8%), delirium (2%), and acute kidney injury (1.4%). In the early period (0-90 days), 12 complications are associated with worse survival. From 3 to 18 months after surgery, only 4 complications are associated with survival: delirium, blood transfusion, reintubation, and pneumonia. After 18 months, only sepsis and blood transfusion are associated with a significant late hazard. CONCLUSIONS: Our analysis confirmed the presence of differential magnitude and time-varying effects on survival of individual complications after lung cancer surgery. We conclude that the derived time-dependent hazard ratios can serve as objective weights in future models that enhance performance measurement and focus attention on prevention and management of complications with greatest effects.
OBJECTIVE: Complications adversely affect survival after lung cancer surgery. We tested the hypothesis that effects of complications after lung cancer surgery on survival vary substantially across the spectrum of postoperative complications. METHODS: The Society of Thoracic Surgeons General Thoracic Surgery Database was linked to Medicare data for lung cancer resections from 2002 through 2013. Linkage was achieved for 29,899 patients. A survival model was created that included operative complications as explanatory variables and adjusted for relevant baseline covariates. Because of violation of the proportional hazard assumption, we used time-varying coefficient Cox modeling for the complication variables. RESULTS: Median patient age was 73 years, and 48% were male. Procedures performed were lobectomy in 69%, wedge in 17%, segmentectomy in 7%, bilobectomy in 3%, pneumonectomy in 3%, and sleeve lobectomy in 1%. Most frequent complications were atrial arrhythmia (14%), pneumonia (4.3%), reintubation (3.8%), delirium (2%), and acute kidney injury (1.4%). In the early period (0-90 days), 12 complications are associated with worse survival. From 3 to 18 months after surgery, only 4 complications are associated with survival: delirium, blood transfusion, reintubation, and pneumonia. After 18 months, only sepsis and blood transfusion are associated with a significant late hazard. CONCLUSIONS: Our analysis confirmed the presence of differential magnitude and time-varying effects on survival of individual complications after lung cancer surgery. We conclude that the derived time-dependent hazard ratios can serve as objective weights in future models that enhance performance measurement and focus attention on prevention and management of complications with greatest effects.
Authors: Xing Wei; Hongfan Yu; Wei Dai; Wei Xu; Qingsong Yu; Yang Pu; Yaqin Wang; Jia Liao; Qiang Li; Qiuling Shi Journal: Support Care Cancer Date: 2021-08-27 Impact factor: 3.603
Authors: Mariusz Łochowski; Barbara Łochowska; Justyna Chałubińska-Fendler; Izabela Zawadzka; Marek Rębowski; Józef Kozak Journal: Cancer Manag Res Date: 2021-01-18 Impact factor: 3.989
Authors: Kian Banks; Sora Ely; Diana S Hsu; Dana A Dominguez; Rebecca C Gologorsky; Julia Wei; Clara Maxim; Simon K Ashiku; Ashish R Patel; Jeffrey B Velotta Journal: J Thorac Dis Date: 2022-01 Impact factor: 2.895
Authors: Semin Cho; Eunjeong Kang; Ji Eun Kim; U Kang; Hee Gyung Kang; Minsu Park; Kwangsoo Kim; Dong Ki Kim; Kwon Wook Joo; Yon Su Kim; Hyung-Jin Yoon; Hajeong Lee Journal: Cancer Res Treat Date: 2021-01-18 Impact factor: 4.679